CYTOTECH ApS: Financial statements 2023
CVR: 19898504
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CYTOTECH ApS (CVR 19898504) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 182,609 and a net result of DKK -81,311 compared with DKK 50,683 the year before. That is a decrease of 33.1% compared with the year before. Equity in the 2023 report amounted to DKK 156,254. The solvency ratio was 68.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 182,609
- Profit/Loss
- DKK -81,311
- Equity
- DKK 156,254
- Total Assets
- DKK 227,699
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 183 t. | -81 t. | 156 t. | 1 |
| 2022 | - | 273 t. | 51 t. | 238 t. | 1 |
| 2021 | - | 255 t. | -15 t. | 187 t. | 1 |
| 2020 | - | 266 t. | -11 t. | 201 t. | 1 |
| 2019 | - | 378 t. | 149 t. | 212 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CYTOTECH ApS has published its annual report for 2022. Gross profit came to DKK 272,977, and the net result was DKK 50,683.
About CYTOTECH ApS
CYTOTECH ApS is a Danish company of the type Anpartsselskab based in Hellebæk, founded in 1997. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Patrick van Dijk Munch-Fals. The company is owned by Patrick van Dijk Munch-Fals. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 196,108 and a net result of DKK -70,656 compared with DKK -113,059 the year before. Equity in the 2025 report amounted to DKK -27,461.